José Teles

José Teles

Auto-generated profile, based on publicly available information

José Teles

Tailor Bio

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2017 in eLife
Verified
Journal Article
Open access
HMHeather M Meyer
Heather M Meyer
JTJosé Teles
José Teles
PFPau Formosa-Jordan
Pau Formosa-Jordan
YRYassin Refahi
Yassin Refahi
RSRita San-Bento
Rita San-Bento
ARAdrienne H K Roeder
Adrienne H K Roeder
Multicellular development produces patterns of specialized cell types. Yet, it is often unclear how individual cells within a field of identical cells initiate the patterning process. Using live imaging, quantitative image analyses and modeling, we show that during Arabidopsis thaliana sepal development, fluctuations in the concentration of the transcription factor ATML1 pattern a field of identical epidermal cells to differentiate into giant cells interspersed between smaller cells. We find that ATML1 is expressed in all epidermal cells. However, its level fluctuates in each of these cells. If ATML1 levels surpass a threshold during the G2 phase of the cell cycle, the cell will likely enter a state of endoreduplication and become giant. Otherwise, the cell divides. Our results demonstrate a fluctuation-driven patterning mechanism for how cell fate decisions can be initiated through a random yet tightly regulated process.

1 September 2009 in Annals of the New York Academy of Sciences
Verified
Journal Article
Closed access
PDF file
ESElsa Sousa
Elsa Sousa
JCJoana Caetano‐Lopes
Joana Caetano‐Lopes
PPPatrícia Pinto
Patrícia Pinto
FPFernando Manuel Pimnetel-Santos
Fernando Manuel Pimnetel-Santos
JTJosé Teles
José Teles
João Eurico FonsecaJoão Eurico Fonseca
João Eurico Fonseca

15 April 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
DGDiego Garcia-Lopez
Diego Garcia-Lopez
AZAzedine Zoufir
Azedine Zoufir
BHBarbara Hernando
Barbara Hernando
PSPatricia G. Santamaria
Patricia G. Santamaria
ACAlice Cadiz
Alice Cadiz
GMGeoff Macintyre
Geoff Macintyre
Targeting Porcupine (PORCN), a key regulator of the WNT-signalling pathway, has shown therapeutic potential in multiple cancers. Despite strong target engagement and acceptable safety profiles through human phase I clinical trials, low phase II efficacy has stalled further clinical development. Given that aberrant WNT signalling can drive tumorigenesis by inducing chromosomal instability (CIN), we hypothesised that genomic CIN signatures might serve as a predictive biomarker to help improve response rates. Using a controlled in vitro model and single-cell whole-genome sequencing, we demonstrate that acute WNT-activation directly induces three distinct types of CIN: whole genome duplication, replication stress, and impaired homologous recombination. We translated these observations into a composite CIN signature biomarker that significantly correlated with both genetic dependency and pharmacological inhibition of PORCN across 195 and 24 cell lines, respectively. Through a large-scale meta-analysis of patient-derived and cell line xenografts, we established that this composite CIN signature biomarker quantitatively predicts in vivo PORCN inhibitor sensitivity (R=-0.71, p<0.002). By applying an optimised biomarker threshold, refined through modelling of human patient data, to the The Cancer Genome Atlas dataset, we successfully retrospectively modelled previous trial results and identified gastroesophageal cancers as a high-prevalence (36.6%) indication for future development. We validated this strategy in a mouse clinical trial of gastric and esophageal xenografts, where biomarker-guided stratification achieved an objective response rate of 60% and significantly decreased risk of progression (HR=0.21, p=0.0345). These data establish an actionable, trail-ready framework for further PORCN inhibitor clinical development.